Espada G, Pardeo M, Chaitow J, Brown D, Allen R, Zulian F, . . . Martini A. (2011). Efficacy and safety of tocilizumab (TCZ) in patients with systemic juvenile idiopathic arthritis (SJIA): Tender 52-week data. BMC.
Chicago Style (17th ed.) CitationEspada G, et al. Efficacy and Safety of Tocilizumab (TCZ) in Patients with Systemic Juvenile Idiopathic Arthritis (SJIA): Tender 52-week Data. BMC, 2011.
MLA (9th ed.) CitationEspada G, et al. Efficacy and Safety of Tocilizumab (TCZ) in Patients with Systemic Juvenile Idiopathic Arthritis (SJIA): Tender 52-week Data. BMC, 2011.
Warning: These citations may not always be 100% accurate.